Patents/Inventors

Harpreet Singh

TuebingenDE116 patents

145 Patents

US123516162025
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US123398452025
Method and System for Task Planning and Execution Based on User Query
QUANTIPHI, Inc
0 cites
US123092952025
Cloud-based Man-in-the-middle Inspection of Encrypted Traffic Using Cloud-based Multi-tenant HSM Infrastructure
Zscaler, Inc.
0 cites
US122959942025
Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US122959952025
Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US122959962025
Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122972452025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122972542025
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122811462025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122757682025
In Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122757752025
Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122757762025
Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122583822025
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122604342025
System and Method for a Scalable Pricing Engine
Salesforce, Inc.
0 cites
US122470572025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122408772025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122408782025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122342762025
Uterine Cancer Treatments
Immatics Biotechnologies GmbH
0 cites
US122342982025
Immunotherapy Against Several Tumors Including Neuronal and Brain Tumors
Immatics Biotechnologies GmbH
0 cites
US122264662025
Peptides and Combination of Peptides for Use in Immunotherapy Against Breast Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122264672025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US122275562025
Immunotherapy with B*08 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US122214672025
Uterine Cancer Treatments
Immatics Biotechnologies GmbH
0 cites
US122214682025
Peptides and Scaffolds for Use in Immunotherapy Against Head and Neck Squamous Cell Carcinoma and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122214932025
Immunotherapy Against Several Tumors Including Neuronal and Brain Tumors
Immatics Biotechnologies GmbH
0 cites
US122216262025
Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122140252025
Peptides and Combination of Peptides for Use in Immunotherapy Against Pancreatic Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US122028782025
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US121939972025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121939982025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121939992025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121955062025
Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US121955072025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121955082025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121955092025
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121955162025
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US121862762025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121862772025
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121802562024
Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121802592024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121718192024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121730432024
Peptides and Combination of Peptides for Use in Immunotherapy Against Small Cell Lung Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121680432024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121629172024
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US121569052024
CCR8 Peptide and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites
US121509792024
Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121523022024
Multiple-channel Showerhead Design and Methods in Manufacturing
APPLIED MATERIALS, Inc.
0 cites
US121448522024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121026702024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US121039842024
Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US120972492024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US120844862024
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US120845222024
Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US120763792024
A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US120763812024
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US120714582024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US120644652024
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites
US120654712024
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US120594582024
Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US120603992024
Immunotherapy with A*01 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US120604002024
Peptides for Use in Immunotherapy Against Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US120604062024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites
US120559022024
Failure Mode Analytics
SAP SE
0 cites
US120362712024
Peptides and Combination of Peptides as Targets or Active Ingredients for Use in Immunotherapy Against AML and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US120393012024
Development and Implementation of Containerized Applications
Royal Bank Of Canada
0 cites
US120297852024
GINS2 Peptide and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites
US120233722024
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites
US120180642024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites
US120051052024
Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US120063492024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites
US119997742024
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US119864972024
Immunotherapy Against Neuronal and Brain Tumors
Immatics Biotechnologies GmbH
0 cites
US119750422024
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites
US119750582024
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US119694552024
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites
US119650132024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
Immatics Biotechnologies GmbH
0 cites
US119577302024
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
0 cites
US119577422024
Method for Treating Non-small Lung Cancer with a Population of Activated T Cells
Immatics Biotechnologies GmbH
0 cites
US119511602024
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
Immatics Biotechnologies GmbH
0 cites
US119458502024
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US119381762024
Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US119393662024
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US119394002024
Immunotherapy Against Several Tumors Including Lung Cancer
Immatics Biotechnologies GmbH
0 cites
US119394012024
Immunotherapy Against Several Tumors Including Lung Cancer
Immatics Biotechnologies GmbH
0 cites
US119326782024
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US119182612024
Locking System for Femoral Neck Fracture Fixation
Stryker European Operations Limited
0 cites
US119127482024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US119127492024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US119152292024
Currency Exchange System and Methodology
0 cites
US119053192024
Peptides and Combination of Peptides for Use in Immunotherapy Against Small Cell Lung Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118979342024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118979352024
Peptides, Combination of Peptides as Targets and for Use in Immunotherapy Against Gallbladder Cancer and Cholangiocarcinoma and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118979362024
Peptides, Combination of Peptides as Targets and for Use in Immunotherapy
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118903332024
Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118903342024
Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118834622024
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118722702024
A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118733292024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118664732024
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
0 cites
US118665172024
Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
USD10098172024
Shadow Ring Lift Pin
Applied Materials, Inc.
0 cites
US118590172024
Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118502742023
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118533442023
Systems and Methods for Using Hierarchical Ordered Weighted Averaging for Providing Personalized Media Content
Spotify AB
0 cites
US118396432023
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
Immatics Biotechnologies GmbH
0 cites
US118331932023
A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118331942023
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118264092023
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118264102023
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US118144462023
Immunotherapy Against Several Tumors Including Lung Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US117938662023
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US117865842023
Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers
Immatics Biotechnologies GmbH
0 cites
US117901492023
System and Method for Tracing Nets Across Multiple Fabrics in an Electronic Design
Cadence Design Systems, Inc.
0 cites
US117796052023
Immunotherapy with B*08 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
Immatics Biotechnologies GmbH
0 cites
US117595072023
Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
USD09978932023
Shadow Ring Lift Plate
APPLIED MATERIALS, Inc.
0 cites
USD09978942023
Shadow Ring Lift Assembly
Applied Materials, Inc.
0 cites
US117448822023
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US117461952023
Process for Forming a Powder
0 cites
US117320212023
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US117024602023
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116857692023
Peptides for Use in Immunotherapy Against Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116800892023
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116739172023
Peptides, Combination of Peptides, and Cell Based Medicaments for Use in Immunotherapy Against Urinary Bladder Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116676852023
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116552802023
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116552812023
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116482762023
Immunotherapy Against Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116482922023
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116291772023
B*44 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116187742023
Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including NSCLC, SCLC and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116074462023
Personalized Immunotherapy Against Several Neuronal and Brain Tumors
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116078642023
Laminate Film Structures Having Barrier Adhesive Layer
DOW GLOBAL TECHNOLOGIES LLC
0 cites
US116083702023
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US116033972023
Immunotherapy with B*07 Restricted Peptides and Combination of Peptides Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115977522023
Peptides and Combination of Peptides and Scaffolds Thereof for Use in Immunotherapy Against Colorectal Carcinoma (CRC) and Other Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115769542023
Method for Treating Non-small Lung Cancer with a Population of Activated Cells
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115769552023
A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115674602023
Failure Mode Analytics
SAP SE
0 cites
US115595722023
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115541642023
A*03 Restricted Peptides for Use in Immunotherapy Against Cancers and Related Methods
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115477502023
Peptides and T Cells for Use in Immunotherapeutic Treatment Hepatocellular Carcinoma
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115491572023
Method for Modifying Surface Grain Structure of the Material and Apparatus Thereof
Shiv Nadar University
0 cites
US115411072023
Peptides and T Cells for Use in Immunotherapeutic Treatment of Various Cancers
IMMATICS BIOTECHNOLOGIES GmbH
0 cites
US115443152023
Systems and Methods for Using Hierarchical Ordered Weighted Averaging for Providing Personalized Media Content
Spotify AB
0 cites